Old Web
English
Sign In
Acemap
>
Paper
>
Venetoclax and Azacitidine in the Treatment of Patients with Relapsed/Refractory Myelodysplastic Syndrome
Venetoclax and Azacitidine in the Treatment of Patients with Relapsed/Refractory Myelodysplastic Syndrome
2021
Amer M. Zeidan
Uma Borate
Daniel A. Pollyea
Andrew M. Brunner
Fernando Roncolato
Jacqueline S. Garcia
Robin Filshie
Olatoyosi Odenike
Anne-Marie Watson
Ravi Krishnadasan
Ashish Bajel
Kiran Naqvi
Jiuhong Zha
Leah Hogdal
Ying Zhou
David Hoffman
Steve Kye
Guillermo Garcia-Manero
Keywords:
Oncology
relapsed refractory
Internal medicine
Azacitidine
Medicine
Venetoclax
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]